Revolutionizing Neuroscience: Animal-Cell-Free Brain Organoids

Researchers at the University of Michigan unveiled a groundbreaking method to create animal-cell-free human brain organoids, facilitating smoother translation of research from the lab to clinical applications, potentially revolutionizing the study and treatment of neurodegenerative conditions ().

New Means of Slowing Neurodegenerative Diseases Discovered
For people suffering from Alzheimer’s, Parkinson’s, and Lou Gehrig’s disease, a new class of potential drugs targets have been discovered.

‘Pioneering research yields an innovative method to produce animal-cell-free human brain organoids, promising easier translation from lab to clinic and enhancing the study and treatment of neurodegenerative diseases. # Neurodegenerative Disease, #Organoids, #Translational Research ’

Tweet it Now

Unleashing Brain Potential

Over the last decade of researching neurologic diseases, scientists have explored the use of human brain organoids as an alternative to mouse models. These self-assembled, 3D tissues derived from embryonic or pluripotent stem cells more closely model the complex brain structure compared to conventional two-dimensional cultures.

Until now, the engineered network of proteins and molecules that give structure to the cells in brain organoids, known as extracellular matrices, often used a substance derived from mouse sarcomas called Matrigel.

That method suffers significant disadvantages, with a relatively undefined composition and batch-to-batch variability.

The latest U-M research, published in Annals of Clinical and Translational Neurology, offers a solution to overcome Matrigel’s weaknesses. Investigators created a novel culture method that uses an engineered extracellular matrix for human brain organoids — without the presence of animal components – and enhanced the neurogenesis of brain organoids compared to previous studies.

Tau Protein Helps Detect Neurodegenerative Diseases
The brain protein amyloid beta accumulates for years prior to tau tangle formation, resulting in Alzheimer's disease.

Game-Changer in Translational Research

“This advancement in the development of human brain organoids free of animal components will allow for significant strides in the understanding of neurodevelopmental biology,” said senior author Joerg Lahann, Ph.D., director of the U-M Biointerfaces Institute and Wolfgang Pauli Collegiate Professor of Chemical Engineering at U-M.

“Scientists have long struggled to translate animal research into the clinical world, and this novel method will make it easier for translational research to make its way from the lab to the clinic.”

The foundational extracellular matrices of the research team’s brain organoids were comprised of human fibronectin, a protein that serves as a native structure for stem cells to adhere, differentiate and mature. They were supported by a highly porous polymer scaffold.

The organoids were cultured for months, while lab staff was unable to enter the building due to the COVID 19-pandemic.

Using proteomics, researchers found their brain organoids developed a cerebral spinal fluid, a clear liquid that flows around the healthy brain and spinal cords. This fluid more closely matched human adult CSF compared to a landmark study of human brain organoids developed in Matrigel.

How Exercise Protects Against Neurodegenerative Diseases
Exercise-induced activation of peripheral systems may improve cognitive function and delay the onset of neurodegenerative diseases like Alzheimer's and Parkinson's.

Future of Neurodegenerative Disease Studies

“When our brains are naturally developing in utero, they are of course not growing on a bed of extracellular matrix produced by mouse cancer cells,” said first author Ayşe Muñiz, Ph.D., who was a graduate student in the U-M Macromolecular Science and Engineering Program at the time of the work.

“By putting cells in an engineered niche that more closely resembles their natural environment, we predicted we would observe differences in organoid development that more faithfully mimics what we see in nature.”

The success of these xenogeneic-free human brain organoids opens the door for reprogramming with cells from patients with neurodegenerative diseases, says co-author Eva Feldman, M.D., Ph.D., director of the ALS Center of Excellence at U-M and James W. Albers Distinguished Professor of Neurology at U-M Medical School.

“There is a possibility to take the stem cells from a patient with a condition such as ALS or Alzheimer’s and, essentially, build an avatar mini brain of that patient to investigate possible treatments or model how their disease will progress,” Feldman said.

“These models would create another avenue to predict disease and study treatment on a personalized level for conditions that often vary greatly from person to person.”

Reference:

Engineered extracellular matrices facilitate brain organoids from human pluripotent stem cells - (https://onlinelibrary.wiley.com/doi/10.1002/acn3.51820)

Source-Eurekalert